DE10075031I2 - Zusammensetzung zur kontrollierten Abgabe eines Wirkstoffs. - Google Patents
Zusammensetzung zur kontrollierten Abgabe eines Wirkstoffs.Info
- Publication number
- DE10075031I2 DE10075031I2 DE2000175031 DE10075031C DE10075031I2 DE 10075031 I2 DE10075031 I2 DE 10075031I2 DE 2000175031 DE2000175031 DE 2000175031 DE 10075031 C DE10075031 C DE 10075031C DE 10075031 I2 DE10075031 I2 DE 10075031I2
- Authority
- DE
- Germany
- Prior art keywords
- composition
- active ingredient
- controlled release
- release
- controlled
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N25/00—Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests
- A01N25/26—Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests in coated particulate form
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2813—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/282—Organic compounds, e.g. fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/282—Organic compounds, e.g. fats
- A61K9/2826—Sugars or sugar alcohols, e.g. sucrose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
- A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
- A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Toxicology (AREA)
- Pest Control & Pesticides (AREA)
- Plant Pathology (AREA)
- Agronomy & Crop Science (AREA)
- Dentistry (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Environmental Sciences (AREA)
- Inorganic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Separation Using Semi-Permeable Membranes (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP84109832A EP0171457B1 (de) | 1984-08-17 | 1984-08-17 | Zusammensetzung zur kontrollierten Abgabe eines Wirkstoffes und ihre Herstellung |
Publications (2)
Publication Number | Publication Date |
---|---|
DE10075031I1 DE10075031I1 (de) | 2001-01-18 |
DE10075031I2 true DE10075031I2 (de) | 2004-07-01 |
Family
ID=8192120
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE2000175031 Active DE10075031I2 (de) | 1984-08-17 | 1984-08-17 | Zusammensetzung zur kontrollierten Abgabe eines Wirkstoffs. |
DE3486409T Expired - Lifetime DE3486409T2 (de) | 1984-08-17 | 1984-08-17 | Zusammensetzung zur kontrollierten Abgabe eines Wirkstoffs. |
DE8484109832T Expired - Fee Related DE3485618D1 (de) | 1984-08-17 | 1984-08-17 | Zusammensetzung zur kontrollierten abgabe eines wirkstoffes und ihre herstellung. |
Family Applications After (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE3486409T Expired - Lifetime DE3486409T2 (de) | 1984-08-17 | 1984-08-17 | Zusammensetzung zur kontrollierten Abgabe eines Wirkstoffs. |
DE8484109832T Expired - Fee Related DE3485618D1 (de) | 1984-08-17 | 1984-08-17 | Zusammensetzung zur kontrollierten abgabe eines wirkstoffes und ihre herstellung. |
Country Status (4)
Country | Link |
---|---|
EP (2) | EP0171457B1 (de) |
CA (2) | CA1239034A (de) |
DE (3) | DE10075031I2 (de) |
NL (1) | NL300007I2 (de) |
Families Citing this family (35)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA1331338C (en) * | 1987-02-03 | 1994-08-09 | Dow Corning Corporation | Aqueous film-forming compositions for controlling the release of active agents and process of making same |
US5310572A (en) * | 1987-02-03 | 1994-05-10 | Dow Corning Corporation | Process for forming a coated active agent-containing article |
GB8717168D0 (en) | 1987-07-21 | 1987-08-26 | Roussel Lab Ltd | Controlled-release device |
IE60383B1 (en) * | 1988-05-27 | 1994-07-13 | Elan Corp Plc | Controlled release pharmaceutical formulation |
US5055300A (en) * | 1988-06-17 | 1991-10-08 | Basic Bio Systems, Inc. | Time release protein |
US5023080A (en) * | 1988-06-17 | 1991-06-11 | Basic Bio Systems, Inc. | Time release protein |
US5079005A (en) * | 1988-06-17 | 1992-01-07 | Gupta Kashmiri L | Time release protein |
US5612059A (en) * | 1988-08-30 | 1997-03-18 | Pfizer Inc. | Use of asymmetric membranes in delivery devices |
IL91398A (en) * | 1988-08-30 | 1994-05-30 | Pfizer | A device for the controlled release of pneumatic substances, including the active substance, surrounded by an asymmetric membrane |
SE8803822D0 (sv) * | 1988-10-26 | 1988-10-26 | Novel dosage form | |
US5178868A (en) * | 1988-10-26 | 1993-01-12 | Kabi Pharmacia Aktiebolaq | Dosage form |
US5024937A (en) * | 1989-04-06 | 1991-06-18 | Dow Corning Corporation | Method for processing aqueous fermentation broths |
US5078888A (en) * | 1989-04-06 | 1992-01-07 | Dow Corning Corporation | Method for processing aqueous fermentation broths |
US5126146A (en) * | 1989-10-23 | 1992-06-30 | Merck & Co., Inc. | Cellulosic coating |
DE69107461T2 (de) * | 1990-08-07 | 1995-06-22 | Pfizer | Verwendung von interfacial polymerisierten membranen in abgabevorrichtungen. |
GB9217295D0 (en) * | 1992-08-14 | 1992-09-30 | Wellcome Found | Controlled released tablets |
ATE173616T1 (de) * | 1992-11-30 | 1998-12-15 | Pfizer | Verabreichungsvorrichtungen mit gestützten flüssigen membranen |
GB9315856D0 (en) * | 1993-07-30 | 1993-09-15 | Wellcome Found | Stabilized pharmaceutical |
US5541231A (en) * | 1993-07-30 | 1996-07-30 | Glaxo Wellcome Inc. | Stabilized Pharmaceutical |
US7098206B2 (en) | 1998-01-21 | 2006-08-29 | Smithkline Beecham Corporation | Pharmaceutically active morpholinol |
US6998400B2 (en) | 1998-01-22 | 2006-02-14 | Smithkline Beecham Corporation | Pharmaceutically active morpholinol |
JP2002501892A (ja) | 1998-01-29 | 2002-01-22 | セプラコア インコーポレーテッド | 光学的に純粋な(−)−ビュープロピオンの薬学的使用 |
AU2349999A (en) | 1998-01-29 | 1999-08-16 | Sepracor, Inc. | Pharmacological uses of pure (+) -bupropion |
US6033686A (en) * | 1998-10-30 | 2000-03-07 | Pharma Pass Llc | Controlled release tablet of bupropion hydrochloride |
US6855820B2 (en) | 1999-01-20 | 2005-02-15 | Smithkline Beecham Corporation | Pharmaceutically active morpholinol |
US6734213B2 (en) | 1999-01-20 | 2004-05-11 | Smithkline Beecham Corporation | Pharmaceutically active morpholinol |
US6723342B1 (en) | 1999-02-08 | 2004-04-20 | Fmc Corporation | Edible coating composition |
US6432448B1 (en) | 1999-02-08 | 2002-08-13 | Fmc Corporation | Edible coating composition |
US6337328B1 (en) | 1999-03-01 | 2002-01-08 | Sepracor, Inc. | Bupropion metabolites and methods of use |
US6342496B1 (en) | 1999-03-01 | 2002-01-29 | Sepracor Inc. | Bupropion metabolites and methods of use |
US6500462B1 (en) | 1999-10-29 | 2002-12-31 | Fmc Corporation | Edible MCC/PGA coating composition |
GB0025208D0 (en) | 2000-10-13 | 2000-11-29 | Euro Celtique Sa | Delayed release pharmaceutical formulations |
AU2002225763A1 (en) | 2000-11-28 | 2002-06-11 | Fmc Corporation | Edible pga(propylene glycol alginate) coating composition |
US8586085B2 (en) | 2004-11-08 | 2013-11-19 | Biokey, Inc. | Methods and formulations for making pharmaceutical compositions containing bupropion |
KR100670798B1 (ko) | 2004-12-17 | 2007-01-17 | 한국전자통신연구원 | 데이터베이스 캐시 시스템 |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2011587A (en) * | 1934-03-24 | 1935-08-20 | Kelp Ol Lab Inc | Coating for medical compound |
US2602040A (en) * | 1949-06-28 | 1952-07-01 | Givaudan Corp | Enteric coated sympatholytic composition |
US4060598A (en) * | 1967-06-28 | 1977-11-29 | Boehringer Mannheim G.M.B.H. | Tablets coated with aqueous resin dispersions |
SE324859B (de) * | 1967-09-04 | 1970-06-15 | Ercopharm As | |
US3538214A (en) * | 1969-04-22 | 1970-11-03 | Merck & Co Inc | Controlled release medicinal tablets |
DE2010416B2 (de) * | 1970-03-05 | 1979-03-29 | Hoechst Ag, 6000 Frankfurt | Oral anwendbare Arzneiform mit Retardwirkung |
US4016880A (en) * | 1976-03-04 | 1977-04-12 | Alza Corporation | Osmotically driven active agent dispenser |
DD146547A5 (de) * | 1978-07-15 | 1981-02-18 | Boehringer Sohn Ingelheim | Arzneimittel-retardform mit unloeslichen poroesen diffusionshuellen |
US4425363A (en) * | 1981-05-14 | 1984-01-10 | Burroughs Wellcome Co. | Treatment of tardive dyskinesia in mammals |
US4428926A (en) * | 1981-12-18 | 1984-01-31 | Key Pharmaceuticals, Inc. | Sustained release propranolol system |
JPS58134019A (ja) * | 1982-02-05 | 1983-08-10 | Ono Pharmaceut Co Ltd | プロスタグランジン含有持続放出型三層状フイルム製剤及びその製造方法 |
IT1198386B (it) * | 1982-07-06 | 1988-12-21 | Lepetit Spa | Un prodotto a rilascio protratto contenente il suloctidile |
IL70071A (en) * | 1982-11-01 | 1987-12-31 | Merrell Dow Pharma | Multilayered sustained release pharmaceutical tablets having non-uniform distribution of active ingredient |
GB8322007D0 (en) * | 1983-08-16 | 1983-09-21 | Wellcome Found | Pharmaceutical delivery system |
EP0159604B1 (de) * | 1984-04-09 | 1990-11-07 | Toyo Boseki Kabushiki Kaisha | Präparat mit verzögerter Freigabe zum Aufbringen auf die Schleimhäute der Mundhöhle |
-
1984
- 1984-08-17 DE DE2000175031 patent/DE10075031I2/de active Active
- 1984-08-17 CA CA000461272A patent/CA1239034A/en not_active Expired
- 1984-08-17 DE DE3486409T patent/DE3486409T2/de not_active Expired - Lifetime
- 1984-08-17 EP EP84109832A patent/EP0171457B1/de not_active Expired - Lifetime
- 1984-08-17 EP EP91202100A patent/EP0467488B1/de not_active Expired - Lifetime
- 1984-08-17 DE DE8484109832T patent/DE3485618D1/de not_active Expired - Fee Related
-
1992
- 1992-07-10 CA CA616401A patent/CA1321754B/en not_active Expired - Lifetime
-
2000
- 2000-05-22 NL NL300007C patent/NL300007I2/nl unknown
Also Published As
Publication number | Publication date |
---|---|
EP0171457A1 (de) | 1986-02-19 |
NL300007I1 (nl) | 2000-08-01 |
CA1321754B (en) | 1993-08-31 |
EP0467488A3 (en) | 1992-04-15 |
DE3485618D1 (de) | 1992-04-30 |
CA1239034A (en) | 1988-07-12 |
DE3486409T2 (de) | 1996-04-25 |
EP0467488B1 (de) | 1995-10-11 |
NL300007I2 (nl) | 2001-03-01 |
EP0467488A2 (de) | 1992-01-22 |
DE10075031I1 (de) | 2001-01-18 |
EP0171457B1 (de) | 1992-03-25 |
DE3486409D1 (de) | 1995-11-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE10075031I2 (de) | Zusammensetzung zur kontrollierten Abgabe eines Wirkstoffs. | |
ES263908Y (es) | "bloque perfeccionado para la construccion de edificios". | |
MX10621A (es) | Compuestos de piperazinil heterociclicos y procedimiento para su preparacion. | |
ES514750A0 (es) | "procedimiento para la preparacion de n-fenil-sulfonil-n'-pirimidinil- y -triacinil-ureas". | |
ES516648A0 (es) | "procedimiento para la preparacion de n-(2-piridiloxifenil)-n-benzoilureas substituidas". | |
ES539822A0 (es) | Procedimiento para la preparacion de pirazolopiridinas. | |
ES512045A0 (es) | "procedimiento de preparar compuestos benzoxepinicos y analogos". | |
ES515453A0 (es) | "procedimiento para la preparacion de esteres perfluoroalcohilicos". | |
IT8124141A0 (it) | Procedimento per lapreparazione di 4'-deossi-daunorubicina 4'-deossi-doxorubicina. | |
IT8521570A0 (it) | Procedimento di preparazione di microlattici invertiti ed i microlattici invertiti ottenuti. | |
ES514505A0 (es) | "procedimiento para la preparacion de 1-amino-4-hidroxi-antraquinonas". | |
ES508293A0 (es) | "procedimiento para la preparacion de derivados de tiazolina". | |
ES514274A0 (es) | "procedimiento para la preparacion de benzotriazoles". | |
ES514394A0 (es) | "procedimiento para la preparacion de metil terci-butileter o etilterci-butileter". | |
ES512949A0 (es) | "procedimiento para la preparacion de imidazolil-propionitrilos". | |
ES514106A0 (es) | "procedimiento para la preparacion de hidrazonocefem-derivados". | |
ES511252A0 (es) | "procedimiento para la preparacion de prostaglandinas". | |
ES513956A0 (es) | "procedimiento para la carbonilacion de olefinas y esteres organicos". | |
ES512415A0 (es) | "procedimiento para la preparacion de derivados de xilita". | |
ES516225A0 (es) | "procedimiento para la preparacion de derivados de bis-aminometil-antraquinona". | |
ES508961A0 (es) | "procedimiento para la preparacion de imidazolil-vinil-eteres". | |
ES508078A0 (es) | "procedimiento para la preparacion de derivados de formamidina". | |
ATE45087T1 (de) | Dosiseinheiten zur gesteuerten freigabe einer wirksubstanz. | |
MX10058A (es) | Composicion herbicida y procedimiento para su preparacion. | |
ES509618A0 (es) | "procedimiento para la preparacion de alcohiltioacilaminoacidos sustituidos". |